RECRUITING

Optical Coherence Tomography (OCT) in Uveitis

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Optical Coherence Tomography (OCT) machines are non-contact instruments that can provide micrometer (one one-thousandths) scale imaging of biological tissue. This allows excellent assessment of the white blood and inflammatory cells seen in uveitis, an inflammation of any or all parts of the uvea (iris, ciliary body, choroid).

Official Title

Objective Grading of Intraocular Inflammation in Uveitis Using Optical Coherence Tomography

Quick Facts

Study Start:2012-03
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT02026128

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age and older
  2. * With one or more of the following clinical features:
  3. 1. \>1+ AC cells;
  4. 2. \>1+ vitreous haze;
  5. 3. presence of vitreous cells;
  6. 4. presence of blood in anterior chamber;
  7. 5. presence of blood in vitreous;
  8. 6. presence of aqueous or vitreous pigment.
  9. * In one of the following diagnostic categories as determined by a uveitis specialists:
  10. 1. uveitis due to ankylosing spondylitis (positive HLA B27 genotype);
  11. 2. uveitis due to sarcoidosis;
  12. 3. uveitis of any additional type;
  13. 4. uveitis masquerade such as pigment dispersion syndrome or Schaffer's sign;
  14. 5. hyphema due to trauma or other causes;
  15. 6. vitreous hemorrhage;
  16. 7. retinal tear.
  1. * Inability to give informed consent;
  2. * Inability to maintain stable fixation for OCT imaging.

Contacts and Locations

Study Contact

Denny Romfh, OD
CONTACT
503-494-4351
romfhd@ohsu.edu
Humberto Martinez, COT
CONTACT
503-494-7712
martinhu@ohsu.edu

Principal Investigator

David Huang, MD, PhD
PRINCIPAL_INVESTIGATOR
Oregon Health and Science University

Study Locations (Sites)

Oregon Health & Science University
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Oregon Health and Science University

  • David Huang, MD, PhD, PRINCIPAL_INVESTIGATOR, Oregon Health and Science University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2012-03
Study Completion Date2025-12

Study Record Updates

Study Start Date2012-03
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Uveitis
  • Inflammation
  • OCT
  • Grading

Additional Relevant MeSH Terms

  • Uveitis